Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Alfasigma acquires Nordic Group B.V. for expansion

PRIVATEAug 11, 2026•about 4 hours ago

Acquiring Company

Alfasigma

Acquired Company

Nordic Group B.V

Bologna

Easttown TownshipManufacturingBiotechnologyHealth CareBiotechnologyHealth Care

Description

Alfasigma is set to acquire Nordic Group B.V., expanding its specialty care portfolio and enhancing its presence in Europe. This acquisition aims to bolster Alfasigma's offerings in innovative healthcare solutions. The strategic move is part of Alfasigma's ongoing efforts to grow its market share in the European pharmaceutical landscape. The transaction underscores Alfasigma's commitment to improving patient care through expanded capabilities.

Company Information

Company

Alfasigma

Location

Bologna, Emilia Romagna, Italy

About

Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution. In Italy, Alfasigma is a leader in the prescription products market where, in addition to its strong focus on gastro-intestinal products, it is present in several primary care therapeutic areas. It is popular with the consumer public for a number of nutraceuticals & food supplements that respond to different needs, and that are well known and deeply rooted in the Italian families experience. Its historical headquarters is in Bologna, to which is added Milan, while the production sites are: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa in Spain and in Shreveport (Louisiana) in the United States. The R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo. Alfasigma's mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.

Predictive Intelligence

Strategic

ML-powered predictions for Alfasigma's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Nordic Group B.V?

Nordic Group B.V was acquired by Alfasigma, based in Bologna. The deal was reported on August 11, 2026. Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. Alfasigma is privately held and operates in Manufacturing.

When did Alfasigma acquire Nordic Group B.V?

Alfasigma's acquisition of Nordic Group B.V was reported on August 11, 2026. Alfasigma is set to acquire Nordic Group B.V., expanding its specialty care portfolio and enhancing its presence in Europe. This acquisition aims to bolster Alfasigma's offerings in innovative healthcare solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Nordic Group B.V do?

Nordic Pharma, Inc. is a US-based subsidiary of Nordic Group B.V. that specializes in innovative therapies for ophthalmological conditions. They recently launched LACRIFILL® Canalicular Gel, a novel treatment for dry eyes. It is privately held, operating in Biotechnology, and is based in Easttown Township.